FierceBiotechOriginal article
{"a":[{"_":"Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal","$":{"href":"/biotech/founded-metsera-backers-sentivera-emerges-15b-inflammatory-disease-deal","hreflang":"en"}}]}
PartnershipPositive
AI Analysis
Summary
Sentivera, founded by Arch Venture Partners and Population Health Partners, secured a licensing deal valued up to $1.5 billion for inflammatory disease assets. The company was launched by investors previously backing Metsera, which was acquired for $10 billion.
Outcome Details
Licensing deal up to $1.5 billion for inflammatory disease assets
Importance:6/10
Sentiment:
0.70
licensing_dealinflammatory_diseasestartup_launchventure_capital
Read the original article
Published by FierceBiotech on August 25, 2026 9:24 AM